Kura Oncology
kuraoncology.com
Actively hiring
Oncology Therapeutics
As featured in
View 1 job
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Jobs
Financials
News
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes PharmExec
Kura Oncology spins out Caspian Therapeutics to apply its menin inhibitor expertise to diabetes - with Eli Lilly validating the science.
Read more
Report
Kura Oncology Appoints Jennifer Fulk as New CFO
Detailed price information for Kura Oncology (KURA-Q) from The Globe and Mail including charting and trades.
Read more
Report
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes
- $50 million financing led by BVF Partners with participation from the T1D Fund, Invus, Montanova, Eli Lilly and Company, Kura Oncology, members of the Kura leadership team, and multiple, successful biotech entrepreneurs - - Preclinical studies with KO-7
Read more
Report
Kura Oncology launches diabetes-focused Caspian Therapeutics
Lilly, T1D Fund back the new firm's $50 million financing
Read more
Report
Report
Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer
- Seasoned public company CFO with deep biopharmaceutical finance experience across commercial operations, R&D portfolio management, investor ...
Read more
Report
Report
Access To Investigational Drugs Outside a Clinical Study
Kura Oncology is committed to realizing the promise of precision medicines for the treatment of cancer. To do this, we conduct clinical studies
Read more
Report
Kura Oncology CEO Buys 100,000 Shares for $1.2 Million. Does This Large Buy Bode Well for Shares in 2026?
Wilson's purchase increases his total equity stake by 9% following a 62% one-year stock return, signaling confidence in the oncology biotech's pipeline.
Read more
Report
Show more news
Salary insights
Compensation ranges based on this company's open jobs
Median
$224k
Typical range
$163k – $300k
Open positions
4
3
Jobs
Senior
66.7%
Architect
33.3%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 2 | $232k | $163k – $300k |
| Architect | 1 | $218k | $218k |
Highest paying role
Senior Director, HR Business Partner
$300k
Normalized to USD per year
People
Teresa Bair
Executive Officer
Brian Powl
Executive Officer
Kathleen Ford
Executive Officer
Troy Wilson
Executive Officer, Director
Stephen Dale
Executive Officer
Diane Parks
Director
Faheem Hasnain
Director
Helen Collins
Director
Thomas Malley
Director
Mary Szela
Director
Carol Schafer
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
61/100
Growing
Open positions
4
2 opened / 4 closed in 30 days
Median time-to-fill
43 days
faster than 31% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Marketing
25% ▼
Leadership
13% ▲
Support
13% ▲
Administrative
13% ▼
Communications
13% ▲
HR
13% ▲
Activity Timeline
New location: United States
Oct 2026
Added SharePoint to stack
Oct 2026
Added ITIL to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
2
Countries
1
Busiest office
San Diego
Loading the map
Headquarters
Builds here
Office with open vacancies
Tap a pin for the office
San Diego
United States
HQ
San Diego, CA
2 open roles 4 posted in 90 days 50-200 est. staff $191k Avg Salary
hires for Leadership, Communications
4930 Directors Place,
Boston
United States
Regional office
Boston, MA
2 open roles 3 posted in 90 days 50-200 est. staff $232k Avg Salary
hires for Communications, HR
2 Seaport Lane,
Jobs
$186k – $218k per year • Equity • In office • 8+ years exp • Bachelor's Degree • San Diego
ITIL
Apply